- Home
- IKT vs WKEY Comparison
IKT vs WKEY Comparison
Compare IKT & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- WKEY
- Stock Information
- Founded
- IKT 2008
- WKEY 1999
- Country
- IKT United States
- WKEY Switzerland
- Employees
- IKT N/A
- WKEY N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- WKEY EDP Services
- Sector
- IKT Health Care
- WKEY Technology
- Exchange
- IKT Nasdaq
- WKEY Nasdaq
- Market Cap
- IKT 111.8M
- WKEY 98.4M
- IPO Year
- IKT 2020
- WKEY N/A
- Fundamental
- Price
- IKT $1.53
- WKEY $9.42
- Analyst Decision
- IKT Hold
- WKEY Strong Buy
- Analyst Count
- IKT 1
- WKEY 2
- Target Price
- IKT N/A
- WKEY $10.50
- AVG Volume (30 Days)
- IKT 109.4K
- WKEY 2.0M
- Earning Date
- IKT 11-14-2025
- WKEY 09-23-2025
- Dividend Yield
- IKT N/A
- WKEY N/A
- EPS Growth
- IKT N/A
- WKEY N/A
- EPS
- IKT N/A
- WKEY N/A
- Revenue
- IKT N/A
- WKEY $11,994,000.00
- Revenue This Year
- IKT N/A
- WKEY $32.29
- Revenue Next Year
- IKT N/A
- WKEY $89.83
- P/E Ratio
- IKT N/A
- WKEY N/A
- Revenue Growth
- IKT N/A
- WKEY N/A
- 52 Week Low
- IKT $1.33
- WKEY $1.75
- 52 Week High
- IKT $4.20
- WKEY $19.80
- Technical
- Relative Strength Index (RSI)
- IKT 47.90
- WKEY 43.32
- Support Level
- IKT $1.55
- WKEY $11.51
- Resistance Level
- IKT $1.67
- WKEY $15.75
- Average True Range (ATR)
- IKT 0.13
- WKEY 2.76
- MACD
- IKT 0.01
- WKEY -0.66
- Stochastic Oscillator
- IKT 51.16
- WKEY 0.46
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.